Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global pulmonology devices market is estimated at US$ 1.4 billion in 2023. The market is projected to reach US$ 3.8 billion by 2033, exhibiting a CAGR of 10.3% from 2023 to 2033.
North America is the leading revenue contributor in the global pulmonology devices market. This is due to the continuous development of innovative products by leading and emerging vendors in developed countries such as the United States and Canada. Bronchoscopes and minimally invasive surgeries have major advantages in terms of efficiency and ability to accelerate the time taken for diagnosis and treatment of lung cancer at the same time.
Key players are striving hard to develop and achieve regulatory approvals for new procedures and interventions. Companies such as CONMED Corporation, Olympus, and Cook Medical Incorporated are launching new products in the pulmonology devices market. The number of surgeries performed in hospitals is expected to increase due to the rise in the number of technologically advanced hospitals. Additionally, an increase in government support for improving the healthcare sector, especially in Asia Pacific, Latin America, Africa, and the Middle East is estimated to boost the market.
In its new study, FMI offers insights into key factors driving demand for pulmonology devices. The study points toward single-use bronchoscopes being the most sought-after due to the Increasing adaption of single-use bronchoscopes in lung cancer. COPD by indication holds more than thirty percent market share, globally. The report also tracks global sales of pulmonology devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and pulmonology devices in particular.
Attributes | Details |
---|---|
Pulmonology Devices Market Value (2022) | US$ 1.3 billion |
Pulmonology Devices Market Value (2023) | US$ 1.4 billion |
Pulmonology Devices Market Expected Value (2033) | US$ 3.8 billion |
Pulmonology Devices Market Projected CAGR (2023 to 2033) | 10.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The number of Bronchoscopy procedures conducted demonstrated a declining trend between 1990 and 2005. This trend reversed and there was a sharp rise in the number of procedures conducted each year from 2005 onwards. Favourable reimbursement implemented for outpatient procedures is another trend, which is expected to increase in the future. The pulmonology devices market is anticipated to benefit from the rising incidence of numerous pulmonary disorders such as acute bronchitis, COPD, lung cancer, asthma and other related respiratory disorders.
The market is expected to witness an increase in the adoption of pulmonology devices with advanced technology and safety features. The rise in public awareness regarding the risks of lung cancer and the benefits of early treatment has increased the adoption rates substantially.
The increasing adoption of diagnostic and therapeutic pulmonology devices is likely to continue owing to the increase in the population of aged people in the world. This will create opportunities for the expansion of the pulmonology devices market size over the forecast period, which is projected to expand at a CAGR close to 10.3% through 2033.
According to the World Health Organization (WHO), the number of cases rose to 113,820,168 and the number of deaths is estimated around 2,527,891 as of 01 March 2021. The increasing respiratory disease complications due to COVID-19 are expected to create lucrative growth opportunities in the pulmonology devices market over the forecast period.
Patients with asthma and COPD are more susceptible to COVID-19 infection, which is anticipated to create growth opportunities for the pulmonology devices market. Government and non-government institutions are increasingly focusing on the rate of morbidity and mortality due to COVID-19 by improving patient care. This also is expected to create lucrative growth opportunities for growth.
Unacceptable Sterilization Methods to Stifle Market Growth
Some worries are connected with the use of reusable/reprocessed endoscopes and supportive instruments. Key factors considered while the option for reusable endoscopes and accessories cost savings and reduction of medical waste as they cost less which makes the treatment affordable.
For example, in developing countries such as India, each new aspiration needle can cost up to US$ 200. Unacceptable sterilization techniques can lead to severe complications and infections such as transferable infections and blood loss. This is likely to hamper the growth of the pulmonary devices market.
Emergence of respiratory illnesses to drive market growth
The rise in the prevalence of respiratory disorders such as lung cancers, asthma, chronic obstructive pulmonary disorders (COPD) and cystic fibrosis each year will boost the market growth. According to World Cancer Research Fund, lung cancer is one of the most common causes of death in 2018 and there were 2 million new cases of lung cancer reported in the year.
According to the Centers for Disease Control and Prevention (CDC), COPD was the third primary cause of death among US women Over 50% of the adult population with pulmonary disorders and tumours were not aware of the condition. Some of the primary causes of pulmonary disorders comprise exposure to changes in temperature, allergens, smoking, respiratory infection, and environmental pollution. For example:
In the United Kingdom, lung cancer is the third most common cause of cancer, accounting for 13% of new cases of cancer. According to Europe COPD coalition 2016 findings, nearly 5% to 12% of adults in Europe may be suffering from severe COPD.
The growing prevalence of the pulmonary disease has increased the demand for novel techniques for accurate diagnosis and treatment. Some of the common factors considered responsible for respiratory conditions are smoking, air pollution, and industrial & chemical pollutants, which decrease the quality of air and increase the geriatric population.
These factors are often considered responsible for the increase in the morbidity and mortality due to pulmonary diseases in developing countries. This will in turn fuel the demand for pulmonary devices.
High expense of the gadgets to impede market growth
Some of the pulmonary device such as endobronchial devices are expensive and categorized as “capital items” by healthcare institutions and organizations. Manufacturers of endoscopic devices include novel techniques and various budget allocation considerations before making the buying decision.
This cost also varies depending on a country’s regulatory policy and availability of products. The cost of some of the consumables and accessories may be relatively low. Additionally, expenditure incurred on equipment maintenance service is another factor that adds to the financial burden of end users. In emerging countries such as India and China, a small share of the overall GDP (4% to 6%) is spent on health care. The percentage share is even lower in countries such as Indonesia and Malaysia. These factors are likely to restrain the pulmonology devices market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Pulmonology Devices Market:
Differentiating Aspects | Pulmonology Devices Market |
---|---|
CAGR (2023 to 2033) | 10.3% |
Market Valuation in 2023 | US$ 1.4 billion |
Projected Market Value in 2033 | US$ 3.8 billion |
Growth Factors | The increased general consciousness of the dangers of lung cancer and the advantageous effects of early treatment has significantly increased adoption rates. |
Opportunities | Technological advancements in pulmonology imaging equipment have broadened the realm of medical device application, thereby expanding the consumer base. |
Key Trends | The use of robotic technology in less-invasive diagnostic, and surgical operations is the most recent industry trend. |
Therapeutic Respiratory Devices Market:
Differentiating Aspects | Therapeutic Respiratory Devices Market |
---|---|
CAGR (2023 to 2033) | 6.5% |
Market Valuation in 2023 | US$ 19 billion |
Projected Market Value in 2033 | US$ 35.6 billion |
Growth Factors | The growing geriatric population, the rising incidence of respiratory illnesses, and the introduction of new-generation items are the primary drivers of market expansion. |
Opportunities | In recent years, home medical devices have grown in prominence and market share. In addition, reputable international producers and other developing vendors are interested in facilitating the development of therapeutic breathing apparatus for home healthcare. |
Key Trends | Handheld uses for both invasive and noninvasive respiration have been commercially introduced in the United States by a respiratory therapy corporation previously identified as International Biophysics Corporation. |
Interventional Pulmonology Market:
Differentiating Aspects | Interventional Pulmonology Market |
---|---|
CAGR (2023 to 2033) | 7% |
Market Valuation in 2023 | US$ 4 billion |
Projected Market Value in 2033 | US$ 7.8 billion |
Growth Factors | Rising lung cancer consciousness along with rising medical expenses for studies and research are anticipated to drive the market's expansion during the forecast time frame. |
Opportunities | Interventional pulmonology procedures are opening up the market opportunities for start ups and major key players of the industry. |
Key Trends | Insurance firms as well as governments all over the world are steadily enacting policies that promote the use of generic drugs |
Cutting Edge Technologies to Spur The Growth of The Nation
Technological innovations in pulmonology imaging devices have widened the scope of application for medical devices thus expanding the customer base. Technological advancements play a very important role in boosting minimally invasive surgery product sales.
The United States-based manufacturers are striving to introduce technologically advanced products to overcome challenges such as charring of tissues caused due to overheating of electrodes to enhance their device performance.
The launch of narrow-band imaging endoscopes, confocal micro endoscopes, and high-definition cameras for endoscopes have increased the demand for these devices.
The advent of robot-assisted endoscopic procedures has resulted in the transformation of the pulmonology devices sector. Intuitive Surgical is a pioneer of this technology. Several United States-based companies are looking for entering this field. The minimally invasive, diagnostic and surgical procedures performed by using robotic technology are adding value to the market. All the above-mentioned technological innovations have given confidence to end-users of endoscopic devices. This factor, in turn, would be driving the market in the next few years. The United States market held a market share of 28.6% in 2022.
United Kingdom to take over the European Industry
The rising prevalence of pulmonary disorders is expected to drive the pulmonology devices market in the United Kingdom According to the Eurostat database in 2015, the share of deaths due to respiratory diseases was highest in the United Kingdom. Europe was the second-leading revenue generator in 2016, owing to significant revenue contributions from Germany and the United Kingdom
A rise in the number of hospitalization among the geriatric population with respiratory problems was recorded in Western European countries. Global vendors are collaborating with leading universities, such as the National Institutes of Health, to gain significant clinical evidence for their products. The market in the United Kingdom is expected to grow at a CAGR of 8.7% over the upcoming decades.
Cost-effectiveness of Equipment to Propel the Japanese Industry
Manufacturers in Japan offer affordable endoscopy devices for pulmonary disorders. For instance, companies such as Olympus Corporation and Boston Scientific are focusing on the manufacturing of wireless endoscopy systems and biopsy devices. Also, domestic firms are focused on the development of low-cost products.
Vendors are also inclined toward strengthening their manufacturing units and distribution channels in Japan, which is projected to increase their market presence and drive pulmonology device sales shortly. The presence of a large geriatric population in Japan with a well-established healthcare market is estimated to propel the demand for endobronchial ultrasound surgeries, as elderly people are at higher risk for conventional surgeries. The Japanese market held a market share of 7.2% in 2022.
Breakthroughs in Product Developments to Boost the Market in Brazil
Brazil is a relatively untapped market as compared to developed countries, which presents significant opportunities for growth of the pulmonary devices market. The prevalence of lung cancer, COPD, asthma, and other non-pulmonary diseases in the country is anticipated to increase in the next few years
Demand for improved and advanced screening tests in Brazil is rising gradually, with an increase in government support, awareness programs, and improvement in the economic conditions of people in the country. Economic growth and healthcare reforms have led to increased government funding for research in the healthcare sector.
Population growth, the presence of high unmet medical needs, and a rise in healthcare-related customer expectations led by improvement in their economic condition have increased the demand for healthcare services in Brazil. The rise in per capita and disposable income has enabled people to avail of expensive medical treatment in Brazil and Mexico.
Lifestyle changes are expected to boost the Latin American market during the forecast period. A focus on the Brazilian market is likely to enable developers and providers of these (endoscopy) products to witness high growth in revenues and gain market share in the next few years.
High Incidence of Obstructive Pulmonary Disorder (COPD) to Raise the Market in Developing Nations
Improvement in healthcare policies in various countries such as Germany, the United Kingdom, and Japan has resulted in increasing adaption of various treatment diagnostics and services, which in turn has increased the life expectancy of the people.
The rising diagnostic rate of respiratory disease is expected to fuel the growth of the pulmonology devices market. A high prevalence of chronic obstructive pulmonary disorder (COPD) among the older population has been noted. Population aged 45 years or above are at higher risk of respiratory diseases.
According to the Global Initiative for Chronic Obstructive Lung Disease, in 2019, 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it each year, making it the third leading cause of death. COPD is not curable but can be managed by proper medication. These programs encourage people to adopt early diagnosis and medication, which is expected to result in increased revenue for the global pulmonology devices market over the forecast period.
Single-Use Bronchoscopes to become Highest Used Equipment over the Forecast Period
Bronchoscopy procedures are routinely used in clinical seating, with approximately USD$ 5 million being undertaken per year in the United States alone. These procedures are generally regarded as safe and are established procedures. Diseases such as cancer, and chronic obstructive pulmonary disorders owing to a rise in risk factors such as smoking, and pollution is driving a large market.
The rising prevalence of pulmonary fibrosis, idiopathic pulmonary fibrosis, occupational sarcoidosis, interstitial pneumonitis, and pulmonary hemorrhage are other factors driving the market. Advancements in technology have led to the development of Bronchoscopes, with an expansion of potential applications. Growing miniaturization has resulted in the growing adoption of advanced thin bronchoscopes with minimally invasive features
Hospitals Segment to Capture Lion’s Share
Hospitals are expected to remain leading end users as they continue to receive significantly higher patient footfall than other categories. Better access to healthcare professionals and advanced procedures within hospitals is contributing to their growth. The consistently rising demand for the latest medical procedures besides improved patient care will boost sales of pulmonary devices in hospitals.
Some of the leading players operating in the market are Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Cook Medical Incorporated, and Ambu A/S Major Manufacturers. These companies are focusing on the development of a wide range of advanced products. Key players in the pulmonology devices market are focusing on enhancing their global and regional presence through acquisitions and collaboration strategies.
leading companies operating in the market are:
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | USD Million for Value and Units for Volume |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa |
Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina , Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, South Africa, GCC Countries |
Key Segments Covered | Product, Indication, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The primary consumer for Pulmonology Devices is the healthcare industry.
North America is poised to stay attractive, projecting a US$ 1.2 billion by 2033.
The market is estimated to secure a valuation of US$ 1.4 billion in 2023.
The market is estimated to reach US$ 3.8 billion by 2033.
The healthcare sector holds high revenue potential.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Pulmonary Biopsy Devices 5.3.1.1. Single- Use Biopsy Forceps 5.3.1.2. Cytology Brushes 5.3.1.3. Microbiology Brushes 5.3.2. Endobronchial Ultrasound (EBUS) Needles 5.3.2.1. Endobronchial Ultrasound Fine Biopsy Needles 5.3.2.2. Endobronchial Ultrasound Transbronchial Aspiration Needles 5.3.3. Airway Stents 5.3.3.1. Silicon Stents 5.3.3.2. Nitinol Stents 5.3.3.3. Stainless Steel Stents 5.3.4. Airway Extraction Baskets 5.3.5. Single-Use Bronchoscopes 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. Lung Cancer 6.3.2. COPD 6.3.3. Foreign Body Extraction 6.3.4. Tracheal and Bronchial Stenosis 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Pulmonology Clinics 7.3.3. Ambulatory Surgical Centers 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Indication 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Indication 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Indication 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Indication 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Indication 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Indication 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Singapore 12.2.1.5. Thailand 12.2.1.6. Indonesia 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of Asia Pacific 12.2.2. By Product 12.2.3. By Indication 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Indication 12.3.4. By End User 12.4. Key Takeaways 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product 13.2.3. By Indication 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Indication 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Product 14.1.2.2. By Indication 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Product 14.2.2.2. By Indication 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Product 14.3.2.2. By Indication 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Product 14.4.2.2. By Indication 14.4.2.3. By End User 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Product 14.5.2.2. By Indication 14.5.2.3. By End User 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Product 14.6.2.2. By Indication 14.6.2.3. By End User 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Product 14.7.2.2. By Indication 14.7.2.3. By End User 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Product 14.8.2.2. By Indication 14.8.2.3. By End User 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Product 14.9.2.2. By Indication 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Product 14.10.2.2. By Indication 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Product 14.11.2.2. By Indication 14.11.2.3. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Product 14.12.2.2. By Indication 14.12.2.3. By End User 14.13. Singapore 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Product 14.13.2.2. By Indication 14.13.2.3. By End User 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Product 14.14.2.2. By Indication 14.14.2.3. By End User 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Product 14.15.2.2. By Indication 14.15.2.3. By End User 14.16. Australia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Product 14.16.2.2. By Indication 14.16.2.3. By End User 14.17. New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Product 14.17.2.2. By Indication 14.17.2.3. By End User 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Product 14.18.2.2. By Indication 14.18.2.3. By End User 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2022 14.19.2.1. By Product 14.19.2.2. By Indication 14.19.2.3. By End User 14.20. Israel 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2022 14.20.2.1. By Product 14.20.2.2. By Indication 14.20.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Boston Scientific Corporation 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. CONMED Corporation 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Olympus Corporation 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Cook Medical Incorporated 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Medi-Globe GmbH 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Ambu A/S 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Verathon, Inc 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Value (US$ Million) & Volume (Units)ed Medical Surgical Services Ltd 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Hunan Vathin 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Micro-Tech (Nanjing) Co., Ltd 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Merit Medical Systems 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Volume (Units) Forecast by Region, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 4: Global Market Volume (Units) Forecast by Product, 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 6: Global Market Volume (Units) Forecast by Indication, 2018 to 2033 Table 7: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 8: Global Market Volume (Units) Forecast by End User, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: North America Market Volume (Units) Forecast by Country, 2018 to 2033 Table 11: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 12: North America Market Volume (Units) Forecast by Product, 2018 to 2033 Table 13: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 14: North America Market Volume (Units) Forecast by Indication, 2018 to 2033 Table 15: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 16: North America Market Volume (Units) Forecast by End User, 2018 to 2033 Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Latin America Market Volume (Units) Forecast by Country, 2018 to 2033 Table 19: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 20: Latin America Market Volume (Units) Forecast by Product, 2018 to 2033 Table 21: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 22: Latin America Market Volume (Units) Forecast by Indication, 2018 to 2033 Table 23: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 24: Latin America Market Volume (Units) Forecast by End User, 2018 to 2033 Table 25: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Europe Market Volume (Units) Forecast by Country, 2018 to 2033 Table 27: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 28: Europe Market Volume (Units) Forecast by Product, 2018 to 2033 Table 29: Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 30: Europe Market Volume (Units) Forecast by Indication, 2018 to 2033 Table 31: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 32: Europe Market Volume (Units) Forecast by End User, 2018 to 2033 Table 33: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 34: Asia Pacific Market Volume (Units) Forecast by Country, 2018 to 2033 Table 35: Asia Pacific Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 36: Asia Pacific Market Volume (Units) Forecast by Product, 2018 to 2033 Table 37: Asia Pacific Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 38: Asia Pacific Market Volume (Units) Forecast by Indication, 2018 to 2033 Table 39: Asia Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 40: Asia Pacific Market Volume (Units) Forecast by End User, 2018 to 2033 Table 41: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 42: MEA Market Volume (Units) Forecast by Country, 2018 to 2033 Table 43: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 44: MEA Market Volume (Units) Forecast by Product, 2018 to 2033 Table 45: MEA Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 46: MEA Market Volume (Units) Forecast by Indication, 2018 to 2033 Table 47: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 48: MEA Market Volume (Units) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Indication, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Volume (Units) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 10: Global Market Volume (Units) Analysis by Product, 2018 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 13: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 14: Global Market Volume (Units) Analysis by Indication, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 17: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 18: Global Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 21: Global Market Attractiveness by Product, 2023 to 2033 Figure 22: Global Market Attractiveness by Indication, 2023 to 2033 Figure 23: Global Market Attractiveness by End User, 2023 to 2033 Figure 24: Global Market Attractiveness by Region, 2023 to 2033 Figure 25: North America Market Value (US$ Million) by Product, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 29: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 30: North America Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 33: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 34: North America Market Volume (Units) Analysis by Product, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 38: North America Market Volume (Units) Analysis by Indication, 2018 to 2033 Figure 39: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 40: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 41: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 42: North America Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 45: North America Market Attractiveness by Product, 2023 to 2033 Figure 46: North America Market Attractiveness by Indication, 2023 to 2033 Figure 47: North America Market Attractiveness by End User, 2023 to 2033 Figure 48: North America Market Attractiveness by Country, 2023 to 2033 Figure 49: Latin America Market Value (US$ Million) by Product, 2023 to 2033 Figure 50: Latin America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 54: Latin America Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 57: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 58: Latin America Market Volume (Units) Analysis by Product, 2018 to 2033 Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 61: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 62: Latin America Market Volume (Units) Analysis by Indication, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 66: Latin America Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 69: Latin America Market Attractiveness by Product, 2023 to 2033 Figure 70: Latin America Market Attractiveness by Indication, 2023 to 2033 Figure 71: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 73: Europe Market Value (US$ Million) by Product, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 75: Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 76: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 77: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 78: Europe Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 79: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 80: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 81: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 82: Europe Market Volume (Units) Analysis by Product, 2018 to 2033 Figure 83: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 84: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 85: Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 86: Europe Market Volume (Units) Analysis by Indication, 2018 to 2033 Figure 87: Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 88: Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 89: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 90: Europe Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 91: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 92: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 93: Europe Market Attractiveness by Product, 2023 to 2033 Figure 94: Europe Market Attractiveness by Indication, 2023 to 2033 Figure 95: Europe Market Attractiveness by End User, 2023 to 2033 Figure 96: Europe Market Attractiveness by Country, 2023 to 2033 Figure 97: Asia Pacific Market Value (US$ Million) by Product, 2023 to 2033 Figure 98: Asia Pacific Market Value (US$ Million) by Indication, 2023 to 2033 Figure 99: Asia Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 100: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 101: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 102: Asia Pacific Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 103: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 104: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 105: Asia Pacific Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 106: Asia Pacific Market Volume (Units) Analysis by Product, 2018 to 2033 Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 110: Asia Pacific Market Volume (Units) Analysis by Indication, 2018 to 2033 Figure 111: Asia Pacific Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 112: Asia Pacific Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 113: Asia Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 114: Asia Pacific Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 115: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: Asia Pacific Market Attractiveness by Product, 2023 to 2033 Figure 118: Asia Pacific Market Attractiveness by Indication, 2023 to 2033 Figure 119: Asia Pacific Market Attractiveness by End User, 2023 to 2033 Figure 120: Asia Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: MEA Market Value (US$ Million) by Product, 2023 to 2033 Figure 122: MEA Market Value (US$ Million) by Indication, 2023 to 2033 Figure 123: MEA Market Value (US$ Million) by End User, 2023 to 2033 Figure 124: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: MEA Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 127: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 128: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 129: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 130: MEA Market Volume (Units) Analysis by Product, 2018 to 2033 Figure 131: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 132: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 133: MEA Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 134: MEA Market Volume (Units) Analysis by Indication, 2018 to 2033 Figure 135: MEA Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 136: MEA Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 137: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 138: MEA Market Volume (Units) Analysis by End User, 2018 to 2033 Figure 139: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 140: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 141: MEA Market Attractiveness by Product, 2023 to 2033 Figure 142: MEA Market Attractiveness by Indication, 2023 to 2033 Figure 143: MEA Market Attractiveness by End User, 2023 to 2033 Figure 144: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports